Trial Profile
Effect of GLP-1 on Angiogenesis, Angiosafe Type 2 Diabetes Study 1
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin; Sulfonylureas
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Proof of concept
- Acronyms ANGIOSAFE 1
- 14 Jun 2021 Status changed from active, no longer recruiting to completed.
- 07 Feb 2020 Planned End Date changed from 18 Jun 2019 to 1 Jul 2020.
- 07 Feb 2020 Status changed from recruiting to active, no longer recruiting.